New research indicates that individuals who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who end conventional lifestyle regimens.
Research printed in a prominent health publication shows that while overweight individuals often shed substantial amounts of their body weight while on the medication, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals buying such medications need to be cognizant of the danger of rapid rebound weight gain when the medication is stopped," warns expert Dr. Susan Jebb.
That rate of recovery means a reversion to starting mass within about 18 months.
Analyzing Treatments
The analysis, which reviewed 37 of studies involving thousands of participants, contrasted the effects of these new drugs with other pills.
Researchers point out that individuals who lose weight through diet and exercise usually experience a less rapid creep back—around 100 grams monthly—post-intervention.
Understanding the Quick Regain
Experts believe the mode of action of the drugs is key to understanding the amplified rebound.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Long-term administration of the hormone concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication means hunger is uncontrolled, making overeating a significant risk."
A Lifelong Disease?
The NHS advise the injections for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians contend that, given the likelihood of relapse, the therapy might need to be life-long.
This view is supported by pharmaceutical companies, who note that the results "emphasize the chronic character of obesity," akin to managing diseases like hypertension.
Patient Experiences
People who have come off the medication report a sudden resurgence of cravings.
"It was like a trigger flipping and you're instantly extremely hungry," described an individual.
This difficulty is compounded if individuals have not adopted lasting lifestyle or habit changes during treatment.
Growing Use
Recent estimates show that a significant number of people in the UK have used these injections in the past year, with desire being substantial.
- Adoption is more common among women than men.
- The middle-aged age group shows the highest usage rates.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
Finally, experts stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits relies on integrated behavioural support.
